Immediate Impact
2 by Nobel laureates 2 from Science/Nature 66 standout
Citing Papers
Effective extracellular payload release and immunomodulatory interactions govern the therapeutic effect of trastuzumab deruxtecan (T-DXd)
2025 Standout
The present and future of bispecific antibodies for cancer therapy
2024 Standout
Works of Anjali Vaze being referenced
Early Pharmacodynamic Changes in T-Cell Activation, Proliferation, and Cytokine Production Confirm the Mode of Action of BFCR4350A, a FcRH5/CD3 T-Cell-Engaging Bispecific Antibody, in Patients with Relapsed/Refractory Multiple Myeloma
2020
Phase 1b study of anti-NaPi2b antibody-drug conjugate lifastuzumab vedotin (DNIB0600A) in patients with platinum-sensitive recurrent ovarian cancer
2020
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Anjali Vaze | 151 | 92 | 25 | 109 | 14 | 313 | |
| C.E. Newman | 152 | 122 | 19 | 88 | 18 | 366 | |
| Farzana L. Walcott | 128 | 24 | 11 | 122 | 17 | 283 | |
| Margit Stimpfl | 104 | 26 | 28 | 188 | 16 | 363 | |
| Hans Strauß | 83 | 21 | 17 | 59 | 12 | 268 | |
| Craig Vargo | 169 | 37 | 28 | 113 | 20 | 333 | |
| L Anselmi | 183 | 36 | 23 | 84 | 17 | 346 | |
| M. Zahurak | 81 | 13 | 25 | 177 | 11 | 364 | |
| J P Guastalla | 216 | 84 | 17 | 72 | 15 | 318 | |
| Liliane Morel-Maroger Striker | 81 | 30 | 90 | 177 | 9 | 352 | |
| Yan Li | 106 | 20 | 6 | 134 | 19 | 347 |
All Works
Login with ORCID to disown or claim papers
Loading papers...